biotechnology-drugs
Incomible / Shutterstock.com
20 June 2014AmericasHector E. Chagoya

Biotechnology drugs: threats and opportunities

Looking at the trends in patents and in the new drugs working their way along the pipelines of the innovative pharmaceutical companies, it’s clear that biotechnology drugs are the future for the treatment of diseases around the world. It’s also clear that personalised medicine will become a reality for more and more people as biotechnology develops further and the performance of drugs improves.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
9 March 2026   Appeals court upholds lower court’s ruling, clarifying key legal questions concerning patent claims for blood‑testing devices.
Americas
5 March 2026   The healthcare company’s chief IP counsel is researching how law firms and patent attorneys are using AI tools to inform its own guidelines for external legal providers.
Americas
5 March 2026   Moderna settles, agreeing to part with up to $2.25 billion to avoid a trial and secure a licence to continue using the platform underpinning its COVID-19 vaccine.